337 related articles for article (PubMed ID: 12960233)
21. Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans.
Oravecz T; Pall M; Wang J; Roderiquez G; Ditto M; Norcross MA
J Immunol; 1997 Nov; 159(9):4587-92. PubMed ID: 9379060
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of CC chemokine gene expression in human immunodeficiency virus-infected myeloid cells.
Génin P; Mamane Y; Kwon H; LePage C; Wainberg MA; Hiscott J
Virology; 1999 Sep; 261(2):205-15. PubMed ID: 10497106
[TBL] [Abstract][Full Text] [Related]
23. Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages.
Mikulak J; Gianolini M; Versmisse P; Pancino G; Lusso P; Verani A
Virology; 2009 Jul; 390(1):37-44. PubMed ID: 19447459
[TBL] [Abstract][Full Text] [Related]
24. Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates.
Jansson M; Popovic M; Karlsson A; Cocchi F; Rossi P; Albert J; Wigzell H
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15382-7. PubMed ID: 8986820
[TBL] [Abstract][Full Text] [Related]
25. [Role of chemokines in the HIV infection process].
Proost P; Schols D
Verh K Acad Geneeskd Belg; 2002; 64(6):403-20. PubMed ID: 12649932
[TBL] [Abstract][Full Text] [Related]
26. Dichotomous effects of beta-chemokines on HIV replication in monocytes and monocyte-derived macrophages.
Kelly MD; Naif HM; Adams SL; Cunningham AL; Lloyd AR
J Immunol; 1998 Apr; 160(7):3091-5. PubMed ID: 9531262
[TBL] [Abstract][Full Text] [Related]
27. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans.
Wagner L; Yang OO; Garcia-Zepeda EA; Ge Y; Kalams SA; Walker BD; Pasternack MS; Luster AD
Nature; 1998 Feb; 391(6670):908-11. PubMed ID: 9495345
[TBL] [Abstract][Full Text] [Related]
28. Increased CD4 and CCR5 expression and human immunodeficiency virus type 1 entry in CD40 ligand-stimulated macrophages.
Bergamini A; Bolacchi F; Pesce CD; Carbone M; Cepparulo M; Demin F; Rocchi G
J Infect Dis; 2002 Jun; 185(11):1567-77. PubMed ID: 12023762
[TBL] [Abstract][Full Text] [Related]
29. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.
Trkola A; Paxton WA; Monard SP; Hoxie JA; Siani MA; Thompson DA; Wu L; Mackay CR; Horuk R; Moore JP
J Virol; 1998 Jan; 72(1):396-404. PubMed ID: 9420238
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
[TBL] [Abstract][Full Text] [Related]
31. Monocyte chemoattractant protein-2 (CC chemokine ligand 8) inhibits replication of human immunodeficiency virus type 1 via CC chemokine receptor 5.
Yang OO; Garcia-Zepeda EA; Walker BD; Luster AD
J Infect Dis; 2002 Apr; 185(8):1174-8. PubMed ID: 11930329
[TBL] [Abstract][Full Text] [Related]
32. The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages.
Kedzierska K; Crowe SM; Turville S; Cunningham AL
Rev Med Virol; 2003; 13(1):39-56. PubMed ID: 12516061
[TBL] [Abstract][Full Text] [Related]
33. Lack of good correlation of serum CC-chemokine levels with human immunodeficiency virus-1 disease stage and response to treatment.
Ye P; Kazanjian P; Kunkel SL; Kirschner DE
J Lab Clin Med; 2004 May; 143(5):310-9. PubMed ID: 15122175
[TBL] [Abstract][Full Text] [Related]
34. Increased plasma levels of the C-C chemokine RANTES in patients with primary HIV-1 infection.
Malnati MS; Tambussi G; Clerici E; Polo S; Algeri M; Nardese V; Furci L; Lazzarin A; Lusso P
J Biol Regul Homeost Agents; 1997; 11(1-2):40-2. PubMed ID: 9418160
[TBL] [Abstract][Full Text] [Related]
35. Macrophages--promise and peril.
TreatmentUpdate; 1998 Dec; 10(10):4-5. PubMed ID: 11366018
[TBL] [Abstract][Full Text] [Related]
36. Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks.
Sáez-Cirión A; Versmisse P; Truong LX; Chakrabarti LA; Carpentier W; Barré-Sinoussi F; Scott-Algara D; Pancino G
Retrovirology; 2006 Nov; 3():81. PubMed ID: 17092330
[TBL] [Abstract][Full Text] [Related]
37. Apical interactions of HIV type 1 with polarized HEC-1 cell monolayer modulate R5-HIV type 1 spread by submucosal macrophages.
Saïdi H; Magri G; Carbonneil C; Bouhlal H; Hocini H; Belec L
AIDS Res Hum Retroviruses; 2009 May; 25(5):497-509. PubMed ID: 19397398
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies.
Aquaro S; Svicher V; Schols D; Pollicita M; Antinori A; Balzarini J; Perno CF
J Leukoc Biol; 2006 Nov; 80(5):1103-10. PubMed ID: 16931601
[TBL] [Abstract][Full Text] [Related]
39. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells.
Verani A; Scarlatti G; Comar M; Tresoldi E; Polo S; Giacca M; Lusso P; Siccardi AG; Vercelli D
J Exp Med; 1997 Mar; 185(5):805-16. PubMed ID: 9120386
[TBL] [Abstract][Full Text] [Related]
40. CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages.
Moriuchi H; Moriuchi M; Combadiere C; Murphy PM; Fauci AS
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15341-5. PubMed ID: 8986813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
